Bill & Melinda Gates Foundation
Grand Challenge: Innovations in Vaccine Manufacturing for Global Markets
For More Information
For additional information, please visit the program’s website for:
This challenge focuses on innovations in vaccine manufacturing platforms designed to lower production cost for vaccines that target diseases of great global burden and that are among the most costly to produce with current technologies. The proposed research and development will focus on at least one of the following: human papillomavirus, inactivated poliovirus, measles-rubella, pentavalent, pneumococcal, or rotavirus vaccine. The ultimate goal of this challenge is to significantly increase global access to priority vaccines by lowering the manufacturing cost required to produce them.
Grand Challenges is open to both foreign and domestic organizations, including non-profit organizations, for-profit companies, international organizations, government agencies and academic institutions.
The foundation will not provide specific funding limits or expectations. The number of awards and quantity of each award amount will depend upon the quality of the proposals received. Proposers are expected to develop a budget commensurate with the scope and scale of the work necessary to achieve the objectives laid out therein.
If College-level review is required, your College will communicate its earlier internal deadlines.
How to Apply